|
| Table 2: Geometric mean ratios (90% CI) of pharmacokinetic parameters,* the probabilities of exceeding the predetermined limits of bioequivalence (80%-125%), and the power test results from a single-dose administration of a test† and a reference‡ oral-suspension formulation of nitazoxanide 500 mg in healthy Mexican adult subjects. |
